vTv Therapeutics Inc. — Form 10-Q
Filed August 6, 2026 · analyzed by the Periodic Agent
10-Q
— Neutral
significance 8/100
What the filing says
Paul J. Sekhri (President, CEO, Executive Chairperson) and Michael Tung (EVP, CFO) certified the Form 10-Q for the quarter ended June 30, 2026, filed August 6, 2026. Both officers certified under SOX Section 302 and 906 that the financial statements fairly present the company's financial condition and results of operations, and that disclosure controls and internal controls over financial reporting are effective. No material weaknesses, significant deficiencies, or management fraud were disclosed.
Why this rating
Routine SOX certifications, standard for all public companies. No disclosure of material control issues or fraud is baseline expectation, not an event.
See more from August 6, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.